Government College for Men

Accredited by NAAC • Affiliated to Yogi Vemana University • Kadapa, Andhra Pradesh

Autonomous NAAC B++ ISO 9001:2015
ADMISSIONS 2026–27 OPEN! UG applications are now being accepted. Fill Inquiry Form →    Learn More
#Title & AuthorsJournal/ConferenceYearType
1 Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Kalpana Panati, Parasuraman Aiya Subramani, Venkata Ramireddy Narala
DOI
Frontiers in Pharmacology
Vol.16, No.1, pp.1712511
2025 int_journal
2 Role of mitochondria in inflammatory lung diseases
Venkata Ramireddy Narala, Sahithi Reddy Narala, Parasuraman Aiya Subramani, Kalpana Panati, Narasaiah Kolliputi
DOI
Frontiers in Pharmacology
Vol.15, No.1, pp.1433961
2024 int_journal
3 In-silico Docking and Dynamics Simulation Analysis of Peroxisome Proliferator-Activated Receptor-Gamma and β-Carotene
Divya Jindal, Parasuraman Aiya Subramani, Kalpana Panati, Praveen Kumar Pasala, Rajeswara Reddy Saddala, Venkata Ramireddy Narala
DOI
Letters in Drug Design & Discovery
Vol.21, No.15, pp.3198-3205
2024 int_journal
4 Natural product ligands of the peroxisome proliferator-activated receptor gamma as anti-inflammatory mediators
Madhavi Derangula, Kumarla K Ruhinaz, Kalpana Panati, Parasuraman Aiya Subramani, Venkatramana RA Tatireddigari, Venkata Ramireddy Narala
DOI
The Natural Products Journal
Vol.13, No.6, pp.25-39
2023 int_journal
5 Virology and Molecular Pathogenesis of Coronavirus Disease 2019: An Update
Kalpana Panati, Lokesh V Timmana, Venkatramana Reddy AT, Rajeswara Reddy Saddala, Venkata Ramireddy Narala
DOI
The Eurasian Journal of Medicine
Vol.54, No.3, pp.299
2022 int_journal
6 Thiamine: a natural peroxisome proliferator-activated receptor Gamma (PPAR-γ) activator
Parasuraman A Subramani, Firdose Begum Shaik, R Dinakaran Michael, Kalpana Panati, Venkata Ramireddy Narala
DOI
Letters in Drug Design & Discovery
Vol.19, No.10, pp.888-896
2022 int_journal
7 Anticancer activities of biogenic silver nanoparticles targeting apoptosis and inflammatory pathways in colon cancer cells
Vydyanath R Narasimha, T Sree Latha, Reddanna Pallu, Kalpana Panati, Venkata Ramireddy Narala
DOI
Journal of Cluster Science
Vol.33, No.5, pp.2215-2231
2022 int_journal
8 Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice
Venkata Ramireddy Narala, Lokesh V Thimmana, Kalpana Panati, Narasaiah Kolliputi
DOI
International Immunopharmacology
Vol.109, pp.108838
2022 int_journal
9 Code inside the codon: the role of synonymous mutations in regulating splicing machinery and its impact on disease
Avik Sarkar, Kalpana Panati, Venkata Ramireddy Narala
DOI
Mutation Research/Reviews in Mutation Research
Vol.790, pp.108444
2022 int_journal
10 An overview on COVID-19 pandemic: from discovery to treatment
Kalpana Panati, Venkatramana RA Tatireddygari, Venkata R Narala
DOI
Infectious Disorders-Drug Targets Disorders
Vol.21, No.7, pp.31-36
2021 int_journal
11 Biochanin A ameliorates ovalbumin-induced airway inflammation through peroxisome proliferator-activated receptor-gamma in a mouse model
Madhavi Derangula, Kalpana Panati, Venkata R Narala
DOI
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)
Vol.21, No.1, pp.145-155
2021 int_journal
12 Electrophilic nitrated fatty acids are potential therapeutic candidates for inflammatory and fibrotic lung diseases
Kalpana Panati, Lokesh V Thimmana, Venkata Ramireddy Narala
DOI
Nitric Oxide
Vol.102, pp.28-38
2020 int_journal
13 Angiotensin-converting enzyme gene polymorphism may be a risk factor for COVID-19 clinical outcome.
Kalpana Panati, Surendranatha Reddy EC, Venkata Ramireddy Narala
DOI
Current Trends in Biotechnology & Pharmacy
Vol.14, No.2, pp.236
2020 int_journal
14 COVID-19 outbreak: an update on therapeutic options
Kalpana Panati, Venkata Ramireddy Narala
DOI
SN Comprehensive Clinical Medicine
Vol.2, No.4, pp.379-380
2020 int_journal
15 Role of Gold Nanoparticles (GNPs) in Cancer Diagnosis and Treatment (in: Nanotechnology in Biology and Medicine)
Kalpana Panati, Parasuraman Aiya Subramani, Dharaneeswara Reddy Devireddy, Venkata Ramireddy Narala
CRC Press
ISBN: 978-1439893784
2019 Book Chapter
16 The nitrated fatty acid, 10-nitrooleate inhibits the neutrophil chemotaxis via peroxisome proliferator-activated receptor gamma in CLP-induced sepsis in mice
Kalpana Panati, Parasuraman Aiya Subramani, Madhusudhana M Reddy, Madhavi Derangula, Venkat RR Arva Tatireddigari, Narasaiah Kolliputi, Venkata Ramireddy Narala
DOI
International Immunopharmacology
Vol.72, pp.159-165
2019 int_journal
17 Expression, purification and biological characterisation of recombinant human irisin (12.5 kDa)
Kalpana Panati, Venkata Ramireddy Narala, Vydyanath R Narasimha, Madhavi Derangula, Venkat RR Arva Tatireddigari, Suneetha Yeguvapalli
DOI
Journal of Genetic Engineering and Biotechnology
Vol.16, No.2, pp.459-466
2018 int_journal
18 Curcumin nanotechnologies and its anticancer activity
Parasuraman Aiya Subramani, Kalpana Panati, Venkata Ramireddy Narala
DOI
Nutrition and cancer
Vol.69, No.3, pp.381-393
2017 int_journal
19 Nanostructures for curcumin delivery: possibilities and challenges (in: Nano-and Microscale Drug Delivery Systems)
Parasuraman A Subramani, Kalpana Panati, Veeranjaneya R Lebaka, Dharaneeswara D Reddy, Venkata Ramireddy Narala
Elsevier
ISBN: 978-0-323-52727-9
2017 Book Chapter
20 Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene polymorphism in pulmonary tuberculosis in the Indian population
Vydyanath R Narasimha, Kalpana Panati, M Gangadhara Reddy, Venkata Ramireddy Narala
DOI
The International Journal of Mycobacteriology
Vol.5, No.3, pp.346-350
2016 int_journal
21 Irisin/FNDC5-An updated review.
K Panati, Y Suneetha, VR Narala
DOI
European Review for Medical & Pharmacological Sciences
Vol.20, No.4, pp.689-697
2016 int_journal
22 Increased yield of high purity recombinant human brain natriuretic peptide by acid hydrolysis of short fusion partner in Escherichia coli
Radha Madhavi Kanumuri, Chitra Bajji, Rajesh R Tummuru, Venkat RR Arva Tatireddigari, Lakshmi Narasu Mangamoori, Kalpana Panati, Venkata Ramireddy Narala
DOI
Protein Expression and Purification
Vol.111, pp.61-67
2015 int_journal
23 Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the TH2 cytokines
Firdose Begum Shaik, Kalpana Panati, Vydyanath R Narasimha, Venkata Ramireddy Narala
DOI
Biochemical and Biophysical Research Communications
Vol.463, No.4, pp.600-605
2015 int_journal
24 The role of nitrated fatty acids and peroxisome proliferator-activated receptor gamma in modulating inflammation
Venkata Ramireddy Narala, Parasuraman Aiya Subramani, Vydyanath R Narasimha, Firdose Begum Shaik, Kalpana Panati
DOI
International Immunopharmacology
Vol.23, No.1, pp.283-287
2014 int_journal
25 Gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor enfuvirtide
Anil Gudipudi, Chitra Bajji, Ravikanth Reddy Kosana, Kalpana Panati, Dakshayani Lomada, Venkat RR Arva Tatireddigari, Venkata Ramireddy Narala
DOI
Biotechnology letters
Vol.36, No.9, pp.1761-1769
2014 int_journal
26 Recombinant approach for the production of HIV fusion inhibitor Enfuvirtide using Escherichia coli
Ravikanth Reddy Kosana, Chitra Bajji, Radha Madhavi Kanumuri, Kalpana Panati, Lakshmi Narasu Mangamoori, Muralikrishna Reddy Tummuru, Venkata Ramireddy Narala
DOI
Protein Expression and Purification
Vol.95, pp.136-142
2014 int_journal
27 Molecular docking of glyceroneogenesis pathway intermediates with peroxisome proliferator-activated receptor-alpha (PPAR-α)
Parasuraman Aiya Subramani, Kalpana Panati, Venkata Ramireddy Narala
DOI
Bioinformation
Vol.9, No.12, pp.629
2013 int_journal
28 Ovarian cancer biology and immunotherapy
T Sree Latha, Kalpana Panati, D Sravan Kumar Gowd, Madhava C Reddy, Dakshayani Lomada
DOI
International reviews of immunology
Vol.33, No.5, pp.428-440
0000 int_journal